Elon Musk has gone a step further to trial brain-computer interface technology on humans. For this, Elon Musk's neurotech startup Neuralink has posted a job for the clinical trial director. This means Neuralink is ready to take brain-chip research to the next stage. Neuralink has previously conducted trials on pigs and monkeys. It also had a chip in a 9-year-old monkey that enabled him to play video games only with his mind. They are trying to create a human-AI symbiosis using startup technology. Elon Musk said last month that its early trial on humans will begin in 2022. It is estimated to include persons with paralysis. This will attempt to gain direct neural control of the computer cursor.
The same post for which the joining is being conducted stated that the post is for a candidate who understands the mission and is willing and eager to go up and forth. The clinical trial director candidate will have to work with the most innovative doctors and top engineers. At the same time, there will be an opportunity to work as the first clinical trial participant of the Neuralink. This was first reported by Bloomberg.
According to Musk, the Neuralink device is coin-sized and can be mounted in a skull or head. The first practical application of Neuralink technology has to be cured by people with brain disorders and illnesses. Elon Musk has also pointed out that the problem of the brain and spine can be easily solved by simply installing a device. According to Musk, chief of SpaceX and Tesla, the potential for Neuralink's brain chip is limitless. This can solve paralysis, hearing, blindness. He also said that in the future you can secure or replay memory. You can also download it to a new body or robot body.